Southern Finance interviews Nobel laureate Craig C. Mello on RNA medicine

Southern Finance and Guangdong Television interviewed Nobel Prize winner Craig C. Mello about RNA interference, the science behind gene regulation and the rise of RNA-based medicines. The conversation highlights how a 1998 discovery has moved from basic biology into therapies now being explored for cardiovascular disease, rare diseases and other conditions.

Why it matters: - RNA interference has moved from a basic biology discovery into a platform for medicines that can target gene activity. - The shift matters because RNA-based technologies are now being investigated and developed for cardiovascular disease, rare diseases and other medical conditions. - Several RNA-based therapies have already entered clinical use, showing that the field has advanced beyond laboratory research.

What happened: - Southern Finance and Guangdong Television interviewed Craig C. Mello, the 2006 Nobel Prize laureate in Physiology or Medicine. - The interview focused on RNA interference, RNA-based medicines and the expanding role of RNA technologies in biomedical research. - The conversation is part of Southern Finance’s “High-Level Interviews: Conversations with Global Scientific Giants” series. - The series features interviews with internationally recognized scientists on science, technology and biomedical research.

The details: - Mello described RNA interference as a process that enables cells to regulate the activity of specific genes. - He compared the mechanism to a natural search system in the human body that identifies specific genetic information and helps regulate its activity. - Mello and Andrew Fire reported the discovery of RNA interference in 1998. - Their work showed that double-stranded RNA could silence specific genes. - The discovery also helped deepen scientific understanding of gene regulation. - Mello said the field reflects researchers’ growing ability to move from understanding biological mechanisms to developing ways to intervene in them. - He also discussed continued advances in RNA research as scientists learn more about gene regulation and its connection to human health.

Between the lines: - The interview underscores how long timelines in basic science can eventually produce practical medical tools. - RNA interference is an example of a mechanism first understood in the lab and later adapted for clinical development. - The focus on RNA technologies also signals broader momentum in biomedical research toward precision approaches that act on gene activity rather than only on symptoms.

What's next: - Researchers are expected to keep expanding RNA-based applications across more disease areas as understanding of gene regulation improves. - Further progress will likely depend on translating deeper molecular knowledge into therapies that can be tested and used in clinical settings. - Mello pointed to continued opportunities for RNA research as the science of gene regulation advances.